Further development and testing of a platform that uses a human protein combined with cancer drugs to target cancer cells while bypassing healthy cells.
Alpha Cancer Technologies Inc.
5 enregistrements totalisant 1,060,018.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Innovation, Sciences et Développement économique Canada | $950,000 | 1 enregistrement |
| Conseil national de recherches Canada | $110,018 | 4 enregistrements |
Enregistrements
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.